APPLICATION OF DRUG-RELATED PROBLEMS APPROACH TO ANALYSIS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS’ SAFETY


Cite item

Full Text

Abstract

A Drug-Related Problem is an event or circumstance involving drug therapy that actually or potentially interferes with desired health outcomes.The aim of the study was the analysis of the adverse drug reactions (ADR) associated with prescription of the non-steroidal anti-inflammatory drugs (NSAIDs) using the DRP PCNE V5.01 qualification system.Materials and methods. The objects of the study were 415 notification forms about adverse drug reactions of NSAIDs recorded in the regional database of spontaneous reports and called ARCADe (Adverse Reactions in Crimea, Autonomic Database) for the period from 1 January 2009 to 31 December of 2018. The study and analysis of the problems associated with drugs were carried out using the qualification system DRP PCNE V5.01 (Pharmaceutical Care Network Europe) 2006 in the modification of Prof. Zimenkovsky.Results. Among other representatives of the NSAID group, Ibuprofen and Diclofenac became the “leaders” in the incidence of ADR. The frequency of ADR cases for Ibuprofen was 142 reports (34.22% of the total number of ADR for NSAIDs), and for Diclofenac it was 90 cases (21.69%). The calculation of DRP values for each of the presented cases made it possible to determine that in 81 (19.51%) and 91 (21.9%) cases, the DRP value was 6 and 7, respectively. DRP values in the range of 8-10 were found in 92 reports. The highest DRPs value was observed after the administration of Parecoxib (13 problems but only one case was found in the database), the DRPs value of Dexketoprofen was 12.5 (95% CI: 7-17) and the DRPs value of Diclofenac combinations was 10 DRPs; 95% CI: 5-17 DRP). The minimum DRPs values were associated with Naproxen, Rofecoxib, and Etoricoxib prescriptions.Conclusion. Using the DRP system in the analysis of NSAIDs, ADRs allow to identify the medicines which have a high risk of causing safety problems, such as Parecoxib, Dexketoprofen and Diclofenac combinations. The prescription of these drugs should be carried out with special cautions and control to the indications and contraindications, the dose and duration of treatment, as well as to a possible interaction of them with concomitant drugs.

About the authors

A. V. Matveev

National Pharmacovigilance Research Center; Medical Academy n. a. S.I. Georgievsky of Vernadskjy CFU

Email: avmcsmu@gmail.com

A. E. Krasheninnikov

National Pharmacovigilance Research Center

Email: anatoly.krasheninnikov@drugsafety.ru

E. A. Egorova

Medical Academy n. a. S.I. Georgievsky of Vernadskjy CFU

Email: elena212007@rambler.ru

E. I. Konyaeva

Medical Academy n. a. S.I. Georgievsky of Vernadskjy CFU

Email: konyaeva.simferopol@gmail.com

References

  1. Binu K.M., Nimmy N.J., Varghese G.P. A survey of Drug related problems identified by community pharmacy in South India // International Journal of Pharmaceutical, chemical and biological sciences. - 2012. - Vol. 2, №2. - P. 368-374.
  2. van Mil J.W., Westerlund L.O., Hersberger K.E., Schaefer M.A. Drug-related problem classification systems // Ann Pharmacother - 2004. - Vol. 38, №5. - P. 859-67.
  3. Roberts M.S., Stokes J.A., King M.A., Lynne T.A., Purdie D.M., Glasziou P.P., Wilson D.A., McCarthy S.T., Brooks G.E., de Looze F.J., Del Mar C.B. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes // Br J Clin Pharmacol. - 2001. - Vol. 51. - P. 257-265.
  4. Shareef J., Sandeep B., Shastry C.S. Assessment of Drug related problems in patients with cardiovascular diseases in a Tertiary care teaching hospital // Journal of Pharmaceutical Care. - 2014. - Vol. 2, №2. - P. 71-76.
  5. Adepu R., Adusumilli P.K. Assessment of Drug related problems in patients with chronic diseases through Health Status Survey in a South Indian Rural Community setting // Indian J Pharm Sci. - 2016. - Vol. 78, №4. - P. 537-542.
  6. Eichenberger P.M., Lambert M.L., Kahmann I.V., van Mil J.W., Hersberger K.E. Classification of drug-related problems with new prescriptions using a modified PCNE classification system // Pharmacy World & Science. - 2010. - Vol. 3, №32. - P. 362-372. doi: 10.1007/s11096-010-9377-x.
  7. Pfister B., Jonsson J., Gustafsson M. Drug-related problems and medication reviews among old people with dementia // BMC Pharmacol Toxicol. - 2017. - № 8. - P. 52. doi: 10.1186/s40360-017-0157-2.
  8. Fog A.F., Kvalvaag G., Engedal K., Straand J. Drug-related problems and changes in drug utilization after medication reviews in nursing homes in Oslo, Norway // Scand J Prim Health Care. - 2017. - Vol. 35, №4. - 329-335. doi: 10.1080/02813432.2017.1397246.
  9. Hong K., Hong Y.D., Cooke C.E. Medication errors in community pharmacies: The need for commitment, transparency, and research // Res Social Adm Pharm. - 2019. - Vol. 15, №7. - P. 823-826. doi: 10.1016/j. sapharm.2018.11.014.
  10. Hammerlein A., Griese N., Schulz M. Survey of Drug-Related Problems Identified by Community Pharmacies // The Annals of Pharmacotherapy. - 2007. - №11. - P. 1852.
  11. Борецька О.Б. Використання системи ліко-пов’язаних проблем (drug-related problems, DRP) для оцінки якості рецептурних призначень в аптечних закладах // Управління якістю медичної та фармацевтичної допомоги. - 2012. - №3. - С. 31-37.
  12. Adusumilli P.K., Adepu R. Drug related problems: An overview of various classification systems // Asian J Pharm Clin Res. - 2014. - Vol. 7, №4. - P. 7-10.
  13. Wilmer C.M., Huiskes V.J.B., Natsch S., Rennings A.J.M., van den Bemt B.J.F., Bos L.M. Drug-related problems in a clinical setting: a literature review and cross-sectional study evaluating factors to identify patients at risk // European Journal of Hospital Pharmacy. - 2015. - Vol. 22, №4. - P. 229-235. Available at: https://ejhp.bmj. com/content/22/4/229.full.
  14. Parthasarathi G., Ramesh M., Kumar J.K., Madaki S. Assessment of Drug Related Problems and Clinical Pharmacists’ Interventions in an Indian teaching hospital // J Pharm Pract Res. - 2003. - №33. - P. 272-274. doi: 10.1002/jppr2003334272.
  15. Abraham R.R. Drug Related Problems and Reactive Pharmacist Interventions for inpatients Receiving Cardiovascular Drugs // IJBMSP. - 2013. - Vol. 3, №2. - P. 42-48.
  16. Krähenbühl-Melcher A., Schlienger R, Lampert M, Haschke M., Drewe J., Krähenbühl S. Drug-related problems in hospitals: a review of the recent literature // Drug Saf. - 2007. - Vol. 30, №5. - P. 379-407.
  17. Forster A.J., Murff H.J., Peterson J.F., Gandhi T.K., Bates D.W. The incidence and severity of adverse events affecting patients after discharge from the hospital // AnnInternMed. - 2003. - Vol. 138, №3. - P. 161-7.
  18. Schlienger R.G., Luscher T.F., Schoenenberger R.A., Haefeli W.E. Academic detailing improves identification and reporting of adverse drug events // Pharm World Sci. - 1999. - Vol. 21, №3. - P. 110-5.
  19. Greeshma M., Lincy S., Maheswari E., Tharanath S., Viswam S. Identification of Drug-related problems by Clinical Pharmacist in Prescription with Polypharmacy: a prospective interventional study // J Young Pharm. - 2018. - Vol. 10, №4. - P. 460-465. doi:10.5530/ jyp.2018.10.100.
  20. Ayalew M.B., Megersa T.N., Mengistu Y.T. Drug-related problems in medical wards of Tikur Anbessa specialized hospital, Ethiopia // J ResPharmPract. - 2015. - Vol. 4, №4. - P. 216-21. doi: 10.4103/2279-042X.167048.
  21. чернов А.А., Клейменова Е.Б., Сычев Д.А., Абильмажинова А.А., Яшина Л.П., Отделенов В.А., Пающик С.А. Причины геморрагических осложнений у пациентов стационара, получающих лечебные дозы антикоагулянтов // Клиническая фармакология и терапия. - 2018. - т. 27, №5. - С. 23-29. doi: 10.32756/0869-5490-2018-5-23-29.
  22. Matveev A.V., Egorova E.A., Matveeva N.V., Krasheninnikov A.E., Dormidor A.G. Adverse reactions of ACE inhibitors. Retrospective analysis of spontaneous reports in local database // The New Armenian Medical Journal. - 2019. - Vol. 13, №2. - P. 10-17. doi: 10.1371/journal. pone.0155385.
  23. ATC/DDD Index 2019. Available at: https://www.whocc. no/atc_ddd_index/.
  24. Eichenberger P.M., Lampert M.L., Kahmann I.V. Classification of drug-related problems with new prescriptions using a modified PCNE classification system // Pharm World Sci. - 2010. - №32. - P. 362-372.
  25. Зіменковський А.Б., Ривак т.Б., Ханик Н.Л. Ліко-пов’язані проблеми фармакотерапії (DRP) та методологія їх оцінки і стандартизації // Раціональна фармакотерапія. - 2011. - №1-2. - С. 16-22.
  26. Зіменковський А.Б., Ривак т.Б., Ханик Н.Л. Концепція DRP як частина філософії раціональної фармакотерапії, інтегрованої з системою фармацевтичної опіки // Раціональна фармакотерапія. - 2011. - №1-2. - С. 23-29.
  27. Classification for Drug related problems. V 6.2. 14.01.2010. Pharmaceutical Care Network Europe Foundation. «The PCNE Classification V 6.2».
  28. Воронков А.В., Дьякова И.Н., Огурцов Ю.А., Жидкова Ю.Ю., Гамзелева О.Ю. Изучение влияния оригинальных многокомпонентных гелей на формирование патологического рубца с использованием нового методического подхода // Экспериментальная и клиническая фармакология. - 2014. - т. 77, №9. - С. 38-42.

Copyright (c) 2019 Matveev A.V., Krasheninnikov A.E., Egorova E.A., Konyaeva E.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies